Insider · CIK 0001857670
Joanne Curley
Files at VTGN (Vistagen Therapeutics, Inc.). First filing -, latest -.
Joanne Curley files SEC Form 4 as director at VTGN (Vistagen Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Joanne Curley has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | VTGN Vistagen Therapeutics, Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +17,600 | $0.00 | $0 | 17,600 | Sep 11, 2025 |
Questions about Joanne Curley
Answered from the filings on this page, as of the latest one.
Is Joanne Curley buying or selling?
Joanne Curley has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Joanne Curley's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joanne Curley has 0.
Where does Joanne Curley file Form 4?
Joanne Curley has filed Form 4 at VTGN (Vistagen Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.